Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CALC
CALC logo

CALC News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CALC News

CalciMedica Reports FY GAAP EPS of -$1.97

Mar 03 2026seekingalpha

Wall Street Analysts Adjust Ratings

Jan 29 2026Benzinga

CalciMedica Discontinues Trial, Stock Faces Volatility

Jan 28 2026stocktwits

CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns

Jan 28 2026Benzinga

U.S. Stocks Mixed as Energy Shares Rise Amid Crude Inventory Decline

Jan 28 2026Benzinga

U.S. Stocks Mostly Higher; Starbucks Beats Q1 Sales Expectations

Jan 28 2026Benzinga

CalciMedica Halts Auxora Clinical Trial Due to Safety Concerns

Jan 28 2026PRnewswire

CalciMedica (CALC) Anticipates Key Phase 2 Data Readout in 2026 with $14.1M Cash Position

Jan 21 2026NASDAQ.COM

CALC Events

03/03 17:00
CalciMedica Files $125M Mixed Securities Shelf
CalciMedica files $125M mixed securities shelf

CALC Monitor News

CalciMedica Halts Auxora Trial Amid Safety Concerns

Jan 28 2026

CALC Earnings Analysis

No Data

No Data

People Also Watch